177 Lu-FAP-2286 Therapy in a Case of Squamous Lung Cancer.

Li, Linwei; Chen, Lingzhi; Zhang, Yanlang; Zhang, Yu; Chen, Yue · Clin Nucl Med · 2025

case_report · Level V

Where this comes from

Abstract

We reported a 72-year-old man who was diagnosed with squamous lung cancer and received 2 cycles of 177 Lu-FAP-2286 treatment. Radiological remission was observed on follow-up FAP imaging 7 months later with squamous cell carcinoma antigen decreased to normal level. No other abnormality monitored by routine laboratory examination was noted.

Medical subject headings